Genmab ROA 2009-2020 | GNMSF

Current and historical return on assets (ROA) values for Genmab (GNMSF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Genmab ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $0.84B $3.38B 30.76%
2020-06-30 $0.84B $3.06B 35.11%
2020-03-31 $0.35B $2.26B 18.00%
2019-12-31 $0.33B $2.27B 18.74%
2019-09-30 $0.15B $1.99B 10.03%
2019-06-30 $0.10B $1.35B 7.99%
2019-03-31 $0.21B $1.33B 17.98%
2018-06-30 $0.20B $1.15B 18.54%
2018-03-31 $0.20B $1.12B 20.07%
2017-12-31 $0.17B $1.00B 18.55%
2017-09-30 $0.17B $0.93B 20.14%
2017-06-30 $0.20B $0.89B 25.69%
2017-03-31 $0.18B $0.78B 25.41%
2016-12-31 $0.18B $0.78B 26.71%
2016-09-30 $0.11B $0.65B 17.88%
2016-06-30 $0.10B $0.63B 17.68%
2016-03-31 $0.08B $0.58B 14.39%
2015-12-31 $0.11B $0.58B 21.83%
2015-09-30 $0.07B $0.52B 13.59%
2015-06-30 $0.07B $0.49B 14.93%
2015-03-31 $0.07B $0.48B 13.43%
2014-12-31 $0.05B $0.51B 10.26%
2014-09-30 $0.05B $0.50B 11.18%
2014-06-30 $0.03B $0.50B 6.10%
2014-03-31 $0.03B $0.51B 6.97%
2013-12-31 $0.02B $0.31B 6.49%
2013-09-30 $-0.05B $0.32B -17.42%
2013-06-30 $-0.06B $0.29B -21.40%
2013-03-31 $-0.06B $0.31B -20.58%
2012-12-31 $-0.08B $0.29B -30.74%
2012-09-30 $-0.03B $0.30B -10.98%
2012-06-30 $-0.09B $0.25B -31.27%
2012-03-31 $-0.10B $0.26B -32.28%
2011-12-31 $-0.11B $0.29B -31.11%
2011-09-30 $-0.12B $0.32B -29.70%
2011-06-30 $-0.05B $0.40B -12.60%
2011-03-31 $-0.05B $0.42B -16.78%
2010-12-31 $-0.06B $0.44B -26.30%
2010-09-30 $-0.03B $0.43B -29.18%
2010-06-30 $-0.05B $0.00B inf%
2010-03-31 $-0.06B $0.00B -38.73%
2009-12-31 $-0.07B $0.00B -47.18%
2009-09-30 $-0.17B $0.00B -54.55%
2009-06-30 $-0.21B $0.57B -70.74%
2009-03-31 $-0.23B $0.00B -144.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.674B $0.805B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $139.404B 9.94
Amgen (AMGN) United States $129.923B 13.58
CSL (CSLLY) Australia $105.271B 0.00
Gilead Sciences (GILD) United States $75.350B 10.02
Vertex Pharmaceuticals (VRTX) United States $55.963B 26.02
Regeneron Pharmaceuticals (REGN) United States $55.353B 19.63
Illumina (ILMN) United States $43.917B 60.40
Moderna (MRNA) United States $38.625B 0.00
Biogen (BIIB) United States $37.570B 6.67
Seagen (SGEN) United States $31.267B 82.58
Alexion Pharmaceuticals (ALXN) United States $26.563B 10.58
BeiGene (BGNE) Cayman Islands $25.802B 0.00
Genmab (GMAB) Denmark $23.927B 28.32
BioNTech SE (BNTX) Germany $23.547B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.942B 0.00
Exact Sciences (EXAS) United States $17.333B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.016B 64.52
Horizon Therapeutics Public (HZNP) Ireland $15.483B 22.13
Alnylam Pharmaceuticals (ALNY) United States $14.488B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.787B 91.51
ARGENX SE-ADR (ARGX) Netherlands $12.661B 0.00
Bio-Techne Corp (TECH) United States $11.772B 75.28
Mirati Therapeutics (MRTX) United States $11.408B 0.00
Guardant Health (GH) United States $11.292B 0.00
QIAGEN (QGEN) Netherlands $10.752B 24.21
Sarepta Therapeutics (SRPT) United States $10.352B 0.00
Repligen (RGEN) United States $10.182B 144.41
ACADIA Pharmaceuticals (ACAD) United States $8.516B 0.00
Ascendis Pharma (ASND) Denmark $8.270B 0.00
Galapagos (GLPG) Belgium $8.146B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.751B 0.00
Denali Therapeutics (DNLI) United States $7.477B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.982B 0.00
Acceleron Pharma (XLRN) United States $6.841B 0.00
Adaptive Biotechnologies (ADPT) United States $6.346B 0.00
Exelixis (EXEL) United States $5.867B 39.40
Amicus Therapeutics (FOLD) United States $5.728B 0.00
Reata Pharmaceuticals (RETA) United States $5.514B 0.00
Novavax (NVAX) United States $5.510B 0.00
Blueprint Medicines (BPMC) United States $5.442B 18.02
SWEDISH ORP BIO (BIOVF) Sweden $5.385B 14.71
Halozyme Therapeutics (HALO) United States $5.333B 246.56
Twist Bioscience (TWST) United States $5.161B 0.00
NeoGenomics (NEO) United States $4.971B 1492.33
China Biologic Products (CBPO) China $4.674B 27.75
Fate Therapeutics (FATE) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $4.381B 14.38
Insmed (INSM) United States $3.980B 0.00
Arena Pharmaceuticals (ARNA) United States $3.771B 0.00
Legend Biotech (LEGN) United States $3.735B 0.00
Vir Biotechnology (VIR) United States $3.697B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.537B 0.00
MorphoSys AG (MOR) Germany $3.510B 127.05
Seres Therapeutics (MCRB) United States $3.147B 0.00
Eidos Therapeutics (EIDX) United States $3.137B 0.00
Alkermes (ALKS) Ireland $2.903B 28.50
Bluebird Bio (BLUE) United States $2.859B 0.00
Global Blood Therapeutics (GBT) United States $2.688B 0.00
Beam Therapeutics (BEAM) United States $2.413B 0.00
I-Mab (IMAB) China $2.331B 0.00
Zymeworks (ZYME) Canada $2.161B 0.00
UniQure (QURE) Netherlands $2.052B 0.00
PHARMA MAR SA (PHMMF) Spain $2.028B 0.00
Intra-Cellular Therapies (ITCI) United States $2.004B 0.00
Sorrento Therapeutics (SRNE) United States $1.988B 0.00
Viela Bio (VIE) United States $1.918B 0.00
Intellia Therapeutics (NTLA) United States $1.911B 0.00
Amarin (AMRN) Ireland $1.807B 0.00
Inovio Pharmaceuticals (INO) United States $1.786B 0.00
Editas Medicine (EDIT) United States $1.772B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.713B 0.00
Mesoblast (MESO) Australia $1.617B 0.00
NGM Biopharmaceuticals (NGM) United States $1.614B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Mersana Therapeutics (MRSN) United States $1.599B 0.00
Revance Therapeutics (RVNC) United States $1.598B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.586B 0.00
Arcus Biosciences (RCUS) United States $1.583B 0.00
Alcobra (ARCT) United States $1.478B 0.00
Sangamo Therapeutics (SGMO) United States $1.450B 0.00
Zealand Pharma (ZEAL) Denmark $1.430B 0.00
Scholar Rock Holding (SRRK) United States $1.415B 0.00
REGENXBIO (RGNX) United States $1.364B 0.00
Ligand Pharmaceuticals (LGND) United States $1.338B 34.67
Coherus BioSciences (CHRS) United States $1.310B 8.66
Athenex (ATNX) United States $1.308B 0.00
Myriad Genetics (MYGN) United States $1.294B 0.00
Zealand Pharma (ZLDPF) Denmark $1.289B 0.00
Travere Therapeutics (TVTX) United States $1.270B 0.00
Adverum Biotechnologies (ADVM) United States $1.267B 0.00
Heska (HSKA) United States $1.200B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.176B 0.00
Precigen (PGEN) United States $1.170B 0.00
Epizyme (EPZM) United States $1.150B 0.00
Cytokineticsorporated (CYTK) United States $1.132B 0.00
Northwest Biotherapeutics (NWBO) United States $1.095B 0.00
Vericel (VCEL) United States $1.076B 0.00
Codexis (CDXS) United States $1.029B 0.00
Pliant Therapeutics (PLRX) United States $1.015B 0.00
Alector (ALEC) United States $1.001B 0.00
Genetron Holdings (GTH) China $0.997B 0.00
Castle Biosciences (CSTL) United States $0.957B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Arvinas (ARVN) United States $0.941B 0.00
Morphic Holding (MORF) United States $0.919B 0.00
Compugen (CGEN) Israel $0.905B 0.00
NantKwest (NK) United States $0.903B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.899B 0.00
Cellectis S.A (CLLS) France $0.899B 0.00
Frequency Therapeutics (FREQ) United States $0.884B 0.00
Protagonist Therapeutics (PTGX) United States $0.831B 0.00
Celldex Therapeutics (CLDX) United States $0.788B 0.00
Cara Therapeutics (CARA) United States $0.764B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
MiMedx (MDXG) United States $0.734B 0.00
Kadmon Holdings (KDMN) United States $0.731B 0.00
AnaptysBio (ANAB) United States $0.724B 0.00
Agenus (AGEN) United States $0.694B 0.00
Sutro Biopharma (STRO) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.676B 34.33
Five Prime Therapeutics (FPRX) United States $0.675B 0.00
MannKind (MNKD) United States $0.675B 0.00
Albireo Pharma (ALBO) United States $0.671B 0.00
VBI Vaccines (VBIV) United States $0.666B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.647B 0.00
Cardiff Oncology (CRDF) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Nabriva Therapeutics AG (NBRV) Ireland $0.628B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.606B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
Geron (GERN) United States $0.584B 0.00
Precision BioSciences (DTIL) United States $0.563B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.525B 0.00
IVERIC Bio (ISEE) United States $0.519B 0.00
Forte Biosciences (FBRX) United States $0.517B 0.00
Anika Therapeutics (ANIK) United States $0.515B 69.62
Avid Bioservices (CDMO) United States $0.509B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.488B 0.00
Dynavax Technologies (DVAX) United States $0.487B 0.00
Merus (MRUS) Netherlands $0.473B 0.00
Prothena (PRTA) Ireland $0.468B 0.00
Amryt Pharma (AMYT) United Kingdom $0.446B 0.00
Puma Biotechnology (PBYI) United States $0.444B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.439B 0.00
UROGEN PHARMA (URGN) United States $0.430B 0.00
WAVE Life Sciences (WVE) Singapore $0.421B 0.00
Kala Pharmaceuticals (KALA) United States $0.421B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.414B 0.00
Spero Therapeutics (SPRO) United States $0.413B 0.00
Starpharma Holdings (SPHRY) Australia $0.404B 0.00
BioDelivery Sciences (BDSI) United States $0.403B 19.00
Trevena (TRVN) United States $0.391B 0.00
AC Immune SA (ACIU) Switzerland $0.390B 0.00
Innate Pharma S.A (IPHA) France $0.387B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
Affimed (AFMD) Germany $0.377B 0.00
Clovis Oncology (CLVS) United States $0.374B 0.00
Cue Biopharma (CUE) United States $0.370B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.365B 0.00
XOMA (XOMA) United States $0.360B 0.00
Syros Pharmaceuticals (SYRS) United States $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
Selecta Biosciences (SELB) United States $0.348B 0.00
ANI Pharmaceuticals (ANIP) United States $0.346B 8.81
CytomX Therapeutics (CTMX) United States $0.338B 0.00
Athersys (ATHX) United States $0.324B 0.00
Kamada (KMDA) Israel $0.302B 14.13
ChromaDex (CDXC) United States $0.301B 0.00
Arbutus Biopharma (ABUS) United States $0.285B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.282B 0.00
NextCure (NXTC) United States $0.281B 0.00
PDL BioPharma (PDLI) United States $0.280B 0.00
Fortress Biotech (FBIO) United States $0.265B 0.00
DBV Technologies S.A (DBVT) France $0.260B 0.00
Verastem (VSTM) United States $0.251B 0.00
TELA Bio (TELA) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.246B 0.00
Pluristem Therapeutics (PSTI) Israel $0.236B 0.00
Aptinyx (APTX) United States $0.207B 0.00
Bellus Health (BLU) Canada $0.194B 0.00
Aptevo Therapeutics (APVO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.178B 0.00
Theratechnologies (THTX) Canada $0.178B 0.00
Dyadic (DYAI) United States $0.178B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.177B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.176B 0.00
ADMA Biologics Inc (ADMA) United States $0.175B 0.00
Cerecor (CERC) United States $0.174B 0.00
AquaBounty Technologies (AQB) United States $0.174B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.156B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
SESEN BIO, INC (SESN) United States $0.153B 0.00
Kindred Biosciences (KIN) United States $0.152B 0.00
Idera Pharmaceuticals (IDRA) United States $0.150B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.143B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Lumos Pharma (LUMO) United States $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Celyad SA (CYAD) Belgium $0.127B 0.00
Exicure (XCUR) United States $0.126B 0.00
Aytu Bioscience (AYTU) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Liquidia Technologies (LQDA) United States $0.119B 0.00
Cogent Biosciences (COGT) United States $0.116B 0.00
TRACON Pharmaceuticals (TCON) United States $0.115B 0.00
Prometic Life Sciences (LMNL) Canada $0.115B 0.00
Orgenesis (ORGS) United States $0.114B 236.50
Windtree Therapeutics (WINT) United States $0.111B 0.00
Cidara Therapeutics (CDTX) United States $0.106B 0.00
Gritstone Oncology (GRTS) United States $0.106B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.104B 0.00
Applied Genetic Technologies (AGTC) United States $0.103B 0.00
Cyclerion Therapeutics (CYCN) United States $0.102B 0.00
Novogen (KZIA) Australia $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Enzo Biochem (ENZ) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
Bionano Genomics (BNGO) United States $0.080B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Curis (CRIS) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.074B 0.00
Evogene (EVGN) Israel $0.073B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.50
MiRagen Therapeutics (MGEN) United States $0.067B 0.00
Adocia (ADOCY) France $0.067B 0.00
Soligenix (SNGX) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.062B 0.00
Cocrystal Pharma (COCP) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Edesa Biotech (EDSA) Canada $0.049B 0.00
Vaccinex (VCNX) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.043B 0.00
Seelos Therapeutics (SEEL) United States $0.042B 0.00
Genetic Technologies (GENE) Australia $0.042B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Titan Pharmaceuticals (TTNP) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
Celsion (CLSN) United States $0.020B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
MedAvail Holdings (MDVL) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00